The announcement followed the company receiving Investigational Device Exemption (IDE) from the US Food and Drug ...
SirPAD is an investigator-initiated, multi-centre, randomized, open-label trial that aims to determine whether the MagicTouch PTA sirolimus-coated balloon is non-inferior to plain old balloon ...
Following the recent IDE Approval by the U.S. Food and Drug Administration (FDA) for MagicTouch PTA, this enrolment heralds ...
Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percu ...
Cagent Vascular, Inc., a developer of serration technology for vessel dilation in endovascular interventions, announced the sta ...
Final results are expected by Q1-Q2 2026. SirPAD is an investigator-initiated, multi-centre, randomized, open-label trial that aims to determine whether the MagicTouch PTA sirolimus-coated balloon is ...